Free Trial
CVE:EQ

EQ (EQ) Stock Price, News & Analysis

EQ logo
C$0.97 0.00 (0.00%)
As of 08/1/2025 03:32 PM Eastern

About EQ Stock (CVE:EQ)

Key Stats

Today's Range
C$0.92
C$0.97
50-Day Range
C$0.92
C$1.01
52-Week Range
C$0.90
C$1.15
Volume
9,003 shs
Average Volume
9,561 shs
Market Capitalization
C$67.51 million
P/E Ratio
N/A
Dividend Yield
0.61%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EQ and its competitors with MarketBeat's FREE daily newsletter.

EQ Stock News Headlines

Subaru Forester 2025 vs Mercedes Benz G 580 EQ
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
See More Headlines

EQ Stock Analysis - Frequently Asked Questions

EQ's stock was trading at C$1.06 on January 1st, 2025. Since then, EQ stock has decreased by 8.5% and is now trading at C$0.97.

Shares of EQ stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that EQ investors own include Revvity (PKI), Norwegian Cruise Line (NCLH), Atara Biotherapeutics (ATRA), Denali Therapeutics (DNLI), Esperion Therapeutics (ESPR), Energy Transfer (ET) and Facedrive (FDVRF).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Advertising Agencies
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:EQ
CIK
N/A
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.66 million
Net Margins
-48.08%
Pretax Margin
N/A
Return on Equity
356.88%
Return on Assets
-18.43%

Debt

Debt-to-Equity Ratio
-105.48
Current Ratio
0.77
Quick Ratio
1.27

Sales & Book Value

Annual Sales
C$9.70 million
Price / Sales
6.96
Cash Flow
C$0.04 per share
Price / Cash Flow
23.33
Book Value
C($0.02) per share
Price / Book
-54.32

Miscellaneous

Outstanding Shares
69,594,000
Free Float
N/A
Market Cap
C$67.51 million
Optionable
Not Optionable
Beta
-0.05
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (CVE:EQ) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners